Antibodies, Heterophile
Antigens, Heterophile
Infectious Mononucleosis
Forssman Antigen
Antibodies
Immunoconglutinins
Hemagglutination Tests
Latex Fixation Tests
False Positive Reactions
Antibody Specificity
Immunoassay
Immunoglobulin M
Immunoglobulin G
Reagent Kits, Diagnostic
Herpesvirus 4, Human
Antibody Formation
Antibodies, Neutralizing
Antibody Affinity
Fluorescent Antibody Technique
Antibodies, Anti-Idiotypic
Binding Sites, Antibody
When is a heterophile antibody not a heterophile antibody? When it is an antibody against a specific immunogen. (1/250)
Heterophile antibodies are antibodies produced against poorly defined antigens. These are generally weak antibodies with multispecific activities. Human anti-animal antibodies that develop as a result of treatments with animal immunoglobulins are antibodies with strong avidities, produced against well-defined antigens. Although heterophile antibodies and human anti-animal antibodies interfere with immunological assays by similar mechanisms, modes for identifying the sources of the antibodies and for circumventing or retarding the interference may differ. Unfortunately, there has not been a well-organized attempt to encourage correct definition of these antibodies. This problem of inexact definition is highlighted by recent articles in this Journal. In the present discussion, we examine the history leading to this problem and discuss the origins and the reasons that the nature of the antibody is important for rectifying the problem. We propose a simple nomenclature for general usage that should appropriately characterize these antibodies in most cases. (+info)Heterotypic protection and induction of a broad heterotypic neutralization response by rotavirus-like particles. (2/250)
The recognition that rotaviruses are the major cause of life-threatening diarrheal disease and significant morbidity in young children has focused efforts on disease prevention and control of these viruses. Although the correlates of protection in children remain unclear, some studies indicate that serotype-specific antibody is important. Based on this premise, current live attenuated reassortant rotavirus vaccines include the four predominant serotypes of virus. We are evaluating subunit rotavirus vaccines, 2/6/7-VLPs and 2/4/6/7-VLPs, that contain only a single VP7 of serotype G1 or G3. In mice immunized parenterally twice, G3 virus-like particles (VLPs) induced a homotypic, whereas G1 VLPs induced a homotypic and heterotypic (G3) serum neutralizing immune response. Administration of three doses of G1 or G3 VLPs induced serum antibodies that neutralized five of seven different serotype test viruses. The inclusion of VP4 in the VLPs was not essential for the induction of heterotypic neutralizing antibody in mice. To confirm these results in another species, rabbits were immunized parenterally with two doses of 2/4/6/7-VLPs containing a G3 or G1 VP7, sequentially with G3 VLPs followed by G1 (G3/G1) VLPs, or with live or psoralen-inactivated SA11. High-titer homotypic serum neutralizing antibody was induced in all rabbits, and low-level heterotypic neutralizing antibody was induced in a subset of rabbits. The rabbits immunized with the G1 or G3/G1 VLPs in QS-21 were challenged orally with live G3 ALA rotavirus. Protection levels were similar in rabbits immunized with homotypic G3 2/4/6/7-VLPs, heterotypic G1 2/4/6/7-VLPs, or G3/G1 2/4/6/7-VLPs. Therefore, G1 2/4/6/7-VLPs can induce protective immunity against a live heterotypic rotavirus challenge in an adjuvant with potential use in humans. Following challenge, broad serum heterotypic neutralizing antibody responses were detected in rabbits parenterally immunized with G1, G3/G1, or G3 VLPs but not with SA11. Immunization with VLPs may provide sufficient priming of the immune system to induce protective anamnestic heterotypic neutralizing antibody responses upon subsequent rotavirus infection. Therefore, a limited number of serotypes of VLPs may be sufficient to provide a broadly protective subunit vaccine. (+info)Enhancement of haemolysis by Newcastle disease virus (NDV) after pre-treatment with heterophile antibody and complement. (3/250)
Pre-treatment of Newcastle disease virus (NDV) with fresh human plasma enhances its haemolytic (HL) capacity by several factors. The effect is due to complement activation by the heterophile anti-chick antibody present in human plasma. All the adult human plasmas tested were effective, also 91/100 human cord blood sera. The antibody was mainly of the IgM class. The enhanced HL was due to integration and transference of the complement 'holed' virus envelope membrane and subsequent leakage of haemoglobin. High concentration of activated complement destroys the integrity of the virus enevelope. Treatment of chick erythrocytes and fibroblasts with human plasma also produced lysis of the cells. (+info)Heterophile antibodies to bovine and caprine proteins causing false-positive human immunodeficiency virus type 1 and other enzyme-linked immunosorbent assay results. (4/250)
Heterophile antibodies are a well-recognized cause of erroneous results in immunoassays. We describe here a 22-month-old child with heterophile antibodies reactive with bovine serum albumin and caprine proteins causing false-positive results to human immunodeficiency virus type 1 and other infectious serology testing. (+info)Heterophile antibodies segregate in families and are associated with protection from type 1 diabetes. (5/250)
Markedly elevated levels of serum IL-4 were reported previously in 50% of a small group of type 1 diabetes nonprogessors. To determine the patterns of expression for this phenotype, a larger cohort of 58 families containing type 1 diabetic patients was examined. Analysis of the two-site ELISA assay used to measure serum IL-4 revealed evidence for heterophile antibodies, i.e., nonanalyte substances in serum capable of binding antibodies mutivalently and providing erroneous analyte (e.g., IL-4) quantification. Interestingly, relatives without type 1 diabetes were significantly more likely to have this phenotype than were patients with the disease (P = 0.003). In addition, the trait appears to have clustered within certain families and was associated with the protective MHC allele DQB1*0602 (P = 0.008). These results suggest that heterophile antibodies represent an in vivo trait associated with self-tolerance and nonprogression to diabetes. (+info)An immunoadhesin incorporating the molecule OX-2 is a potent immunosuppressant that prolongs allo- and xenograft survival. (6/250)
We have established that, in mice receiving donor-specific immunization by the portal vein, the increased graft survival seen is associated with the increased expression of a molecule (OX-2) on a subpopulation of dendritic cells (DC), and polarization of cytokine production to type 2 cytokines on Ag-specific restimulation of cells from these mice. Furthermore, infusion of a mAb to OX-2 blocks both the increased graft survival and the altered cytokine production seen. We have constructed an immunoadhesin in which the extracellular domain of OX-2 is linked to the murine IgG2a Fc region, and we have expressed this molecule (OX-2:Fc) in a eukaryotic (baculovirus) expression system. Incubation of lymphocytes with 50 ng/ml OX-2:Fc inhibits a primary mixed lymphocyte reaction in vitro, as assayed by proliferation and induction of cytotoxic T cells, and also alters cytokine production with decreased IL-2 (IFN-gamma) production and increased IL-4 (IL-10) production. Similarly, in vivo infusion of OX-2:Fc promotes increased allo- and xenograft (both skin and renal grafts) survival and decreases the Ab response to sheep erythrocytes. Our data suggest this molecule might have clinical importance in allo- and xenotransplantation. (+info)Accelerated development and aging of the immune system in p53-deficient mice. (7/250)
Development and aging of the immune system lead to an accumulation of memory T cells over the long term. The predominance of T cells of the memory phenotype in the T cell population induces an age-related decline in protective immune responses. We found that development and aging of the immune system were accelerated in p53-deficient (p53-/-) mice; the accumulation of memory T cells was spontaneously accelerated, and a strong T cell-dependent Ab response and Th2 cytokine expression (IL-4, IL-6, and IL-10) were induced by Ag stimulation in young p53-/- mice in the developmental stage. The high T cell proliferative response in the young mice rapidly progressed to a depressed proliferative response in adult mice. It was suggested that the loss of regulation of the cell cycle, DNA repair, and apoptosis by p53 deficiency potentially leads to immunosenescence with the accumulation of memory T cells. (+info)Accommodated xenografts survive in the presence of anti-donor antibodies and complement that precipitate rejection of naive xenografts. (8/250)
Hamster hearts transplanted into transiently complement-depleted and continuously cyclosporin A (CyA)-immunosuppressed rats survive long-term despite deposition of anti-donor IgM Abs and complement on the graft vascular endothelium. This phenomenon is referred to as "accommodation." The hypothesis tested here is that accommodated xenografts are resistant to IgM Abs and complement that could result in rejection of naive xenografts. After first hamster hearts had been surviving in cobra venom factor (CVF) + CyA-treated rats for 10 days, a time when the anti-donor IgM Ab level was maximal and complement activity had returned to approximately 50% of pretreatment levels, naive hamster hearts or hamster hearts that had been accommodating in another rat for 14 days were transplanted into those rats carrying the surviving first graft. The naive hearts were all hyperacutely rejected. In contrast, a majority of regrafted accommodating hearts survived long-term. There was widespread Ab and activated complement deposition on the vascular endothelium of accommodating first hearts, second accommodating hearts, and rejected second naive hearts. However, only the rejected naive hearts showed extensive endothelial cell damage, myocardial necrosis, fibrin deposition, and other signs of inflammation. Accommodating first and second hearts but not rejected second naive hearts expressed high levels of the protective genes A20, heme oxygenase-1 (HO-1), bcl-2, and bcl-xL. These data demonstrate that accommodated xenografts become resistant to effects of anti-donor IgM Abs and complement that normally mediate rejection of xenografts. We hypothesize that this resistance involves expression by accommodated xenografts of protective genes. (+info)The symptoms of infectious mononucleosis can vary in severity but typically include:
* Fatigue
* Fever
* Sore throat
* Swollen lymph nodes in the neck and armpits
* Enlarged spleen
* Headache
* Muscle weakness
* Rash
* Swollen liver or spleen
Infectious mononucleosis is usually diagnosed through a combination of physical examination, blood tests, and other laboratory tests. Treatment focuses on relieving symptoms and allowing the body to fight the infection on its own.
Prognosis for infectious mononucleosis is generally good, but it can take several weeks to recover fully. Complications are rare but can include inflammation of the spleen, liver disease, and a condition called splenomegaly (enlargement of the spleen).
Prevention includes avoiding close contact with people who have mononucleosis, washing hands frequently, and not sharing eating or drinking utensils. There is no vaccine available to protect against infectious mononucleosis.
Heterophile antibody
Heterophile antibody test
Thyroid-stimulating hormone
History and naming of human leukocyte antigens
Heterophile antigen
Infectious mononucleosis
John Forssman
Cross-reactivity
Pregnancy test
List of MeSH codes (D12.776.124)
List of MeSH codes (D12.776)
Index of immunology articles
Upper Respiratory Tract Infection: Practice Essentials, Background, Pathophysiology
Mononucleosis spot test: MedlinePlus Medical Encyclopedia
NHANES 2011-2012:
Tuberculosis - Quantiferon In Gold Data Documentation, Codebook, and Frequencies
Signs or Symptoms of Acute HIV Infection in a Cohort Undergoing Community-Based Screening - Volume 22, Number 3-March 2016 -...
Pseudo-Outbreak of Infectious Mononucleosis --
Puerto Rico, 1990
Búsqueda | BVS CLAP/SMR-OPS/OMS
Baby’s Pregnancy Calendar
WHO EMRO | Trend and seroprevalence of Epstein-Barr virus in Bahrain: 2001-2015 | Volume 23, issue 12 | EMHJ volume 23, 2017
Find Research outputs - Yonsei University
DeCS
Relative purity of thrombin-based hemostatic agents used in surgery - Fingerprint
- Research Profiles at Washington...
Case Study 2 Nursing Assignment - Eaziessay
Anti-parietal cell antibodies - Clinical Laboratory int.
Fairview Diagnostic Laboratories
Epitope-specific Evolution of Human CD8+ T Cell Responses from Primary to Persistent Phases of Epstein-Barr Virus Infection |...
Antigens cd137. Medical search
Pro Advantage Archives - Aesthetic Record Marketplace
DeCS 2011 - December 22, 2011 version
BAP - Overview: Bone Alkaline Phosphatase, Serum
Mastering your background images in Microsoft Teams
Interferences in quantitative immunochemical methods - Biochemia Medica
FLIVO & FLICA related to Eye Disease Series 4
MeSH Browser
Hyperglobulinemia: Causes & Reasons - Symptoma
antibodies movie - Genoprice
Tests - South West London Pathology
gelsyn-3 injection - Genital Herpes Simplex detection
Antigens2
- These antibodies are directed against a wide variety of interspecies-specific antigens, the best known of which are Forssman, Hanganutziu-Deicher (H-D), and Paul-Bunnell (P-B). Incidence of antibodies to these antigens--i.e., the phenomenon of heterophile antibody response--is useful in the serodiagnosis, pathogenesis, and prognosis of infection and latent infectious states as well as in cancer classification. (bvsalud.org)
- CD stands for cluster of differentiation, which refers to groups of monoclonal antibodies that show similar reactivity with certain subpopulations of antigens of a particular lineage or differentiation stage. (lookformedical.com)
Antigen5
- The presence or absence of EBV viral capsid antigen (VCA) IgG, VCA IgM and EBV nuclear antigen (EBNA) IgG antibodies was recorded. (who.int)
- Antibodies elicited in a different species from which the antigen originated. (bvsalud.org)
- Although these antibodies react with a well known target antigen (H+/K+ ATPase) solely present in the parietal cells of the gastric gland, the use of combined tissue sections in the same reaction well is highly recommended as an aid to avoid confusions with the more frequently found anti-mitochondrial antibodies. (clinlabint.com)
- In the immunoassays, an antibody used as a reagent, detects an analyte (antigen) of interest. (biochemia-medica.com)
- The main characteristic of all immunoassays - from immunoprecipitation to biochip assays - is that the reagent that discovers or quantifies the target analyte (antigen) contains the antibody. (biochemia-medica.com)
Immunoassays1
- Heterophile antibodies in plasma of certain individuals are known to cause interference with immunoassays. (cdc.gov)
Rheumatoid2
- Heterophile antibodies and rheumatoid factor can cause positive interference. (fairview.org)
- Therefore, they cross-react with the antibody or other proteins in the sample, e.g. autoanalyte antibodies, heterophile antibodies, human anti-animal antibodies or rheumatoid factors (12). (biochemia-medica.com)
Monoclonal2
- The effect of heterophile antibodies in the QuantiFERON ® -TB Gold IT ELISA is minimized by the addition of normal mouse serum to the green diluent and the use of F(ab')2 monoclonal antibody fragments as the IFN-γ capture antibody coated the microplate wells. (cdc.gov)
- Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. (lookformedical.com)
Recombinant1
- Recombinant antibodies produced in TRANSGENIC PLANTS . (nih.gov)
Specificity2
- Despite the specificity of the noncovalent bond between analyte and complementary antibody, numerous interferences (Figure 1) are possible, and can cause false increase (positive interference) (1-3) or false decrease of measured result (negative interference) (4,5). (biochemia-medica.com)
- Due to the specific features of the immunoassay technique (cross-reactivity of the antibodies, specificity, technology-dependent sensitivity limits, the matrix effect, etc.), which might cause misleading laboratory report. (biochemia-medica.com)
Agglutination test1
- Twelve persons with positive tests had blood redrawn and tested at a reference laboratory in Puerto Rico using the same heterophile agglutination test. (cdc.gov)
Interference1
- One of the most drastic examples of error in medical practice is the case of false positive chorionic gonadotropin (hCG) test result, described with 22 year old women who underwent, due to unrecognized interference of heterophilic antibodies followed by permanent false positive hCG test result, unnecessary medical interventions: chemotherapy, hysterectomy and segmental lungs resection (7). (biochemia-medica.com)
Immunoassay2
- Rapid chromatographic immunoassay technology identifies heterophile antibodies in whole blood, serum or plasma to aid in the diagnosis of Infectious Mononucleosis. (aestheticrecord.com)
- The COVID-19 IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma) is a lateral flow immunoassay intended for the qualitative detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 Se hela listan på bodytomy.com The blood plasma is then poured or drawn off. (netlify.app)
Serological1
- Anti-parietal cell antibodies (APCA) is a serological marker used for the diagnosis of pernicious anemia and type A chronic gastritis. (clinlabint.com)
Rapid1
- As part of this confidential HIV testing program, routine, individual donation, HIV nucleic acid amplification testing (NAT) has been provided to all rapid antibody-negative participants since June 2007 (samples for NAT are obtained at the time of rapid antibody testing) ( 7 , 10 , 11 ). (cdc.gov)
Infection4
- These antibodies appear during or after an infection with the virus that causes mononucleosis, or mono. (medlineplus.gov)
- This test looks for antibodies called heterophile antibodies, which form in the body during the infection. (medlineplus.gov)
- Although screening programs that rely on point-of-care HIV antibody testing will reliably identify persons with established infection, these tests fail to detect AHI ( 1 , 5 ). (cdc.gov)
- AHI was defined as having a negative or indeterminate HIV antibody test result in the presence of detectable HIV-1 RNA, corresponding to Fiebig stages I-II, with a mean estimated date of infection within the previous 10 days (95% CI 7-14 days) ( 12 ). (cdc.gov)
Presence2
- Elevated levels of IFN-γ in the Nil sample may occur with the presence of heterophile antibodies, or to intrinsic IFN-γ secretion. (cdc.gov)
- However, the use of mouse instead of rat stomach sections to prevent the occurrence of false positives due to the presence of heterophile antibodies might not be a good approach since a false smooth muscle staining could then show up. (clinlabint.com)
Human3
- The major molecular targets of anti-parietal cell antibodies are the alpha- and the beta-subunits of the gastric proton pump H+/K+ ATPase in human autoimmune gastritis. (clinlabint.com)
- Indirect immunofluorescence on human gastric mucosa was the first method used for identifying anti-parietal cell antibodies, back in the early 1960s [4]. (clinlabint.com)
- Low Levels of Human Antibodies to Gametocyte-Infected Erythrocytes Contrasts the PfEMP1-Dominant Response to Asexual Stages in P. falciparum Malaria. (umassmed.edu)
Negative4
- A negative test means there were no heterophile antibodies detected. (medlineplus.gov)
- In kidney/stomach sections, the anti-mitochondrial antibodies show an intense staining of the cytoplasm in the renal tubules, whereas the anti-parietal cell antibodies do not react with the kidney and the image is completely negative (Figure 4). (clinlabint.com)
- Furthermore, if the reaction well also contains rat liver, the cytoplasm of hepatocytes shows a strongly positive labelling with anti-mitochondrial antibodies and negative with anti-parietal cell antibodies. (clinlabint.com)
- Although the noncovalent bound between analyte and complementary antibody is specific, false-positive and false-negative interferences are possible. (biochemia-medica.com)
Specific3
- The Nil samples adjust for background, heterophile antibody effects, or non-specific IFN-γ in blood samples. (cdc.gov)
- In addition, most testing programs in nonhealthcare settings continue to rely on routine antibody testing alone, with specific testing for AHI conducted only for persons with signs or symptoms. (cdc.gov)
- In addition to these specific features of these two patterns, the use of combined tissue sections in the same reaction well can be an aid that allows checking the staining on other structures to clearly differentiate between these two antibody types. (clinlabint.com)
Plasma1
- Mononucleosis heterophile antibodies in whole blood, serum or plasma as an aid in the diagnosis of Infectious Mononucleosis. (netlify.app)
Show1
- The anti-parietal cell antibodies show one of the most distinctive fluorescent patterns in the autoantibody screening by indirect immunofluorescence. (clinlabint.com)
Positive1
- A positive test means heterophile antibodies are present. (medlineplus.gov)
Blood1
- The mononucleosis spot test looks for 2 antibodies in the blood. (medlineplus.gov)
Antigens3
- These heterophile antibodies react to antigens from animal RBCs. (medscape.com)
- [ 32 ] Although anti-VCA IgM is highly suggestive of acute EBV infection, other herpes viruses (eg, cytomegalovirus) can induce IgM antibodies to cell lines that express EBV antigens. (medscape.com)
- These antibodies are directed against a wide variety of interspecies-specific antigens, the best known of which are Forssman, Hanganutziu-Deicher (H-D), and Paul-Bunnell (P-B). Incidence of antibodies to these antigens--i.e., the phenomenon of heterophile antibody response--is useful in the serodiagnosis, pathogenesis, and prognosis of infection and latent infectious states as well as in cancer classification. (bvsalud.org)
Infectious mononucleosis8
- A positive result of a heterophile antibody test also is strong evidence in favor of a diagnosis of infectious mononucleosis. (medscape.com)
- A negative result of an antibody test, particularly during the first week of illness, may indicate that the patient does not have infectious mononucleosis or it could be an infectious mononucleosis-like illness. (medscape.com)
- Heterophile antibody tests are rapid, inexpensive, and specific tests that can be performed from the onset of symptoms of infectious mononucleosis. (medscape.com)
- Specific antibody testing may be necessary to identify the cause of an illness in an individual who does not have a typical case of infectious mononucleosis or has other illnesses that can be cause by EBV. (medscape.com)
- Since heterophile antibodies typically return quicker than EBV specific antibodies, it is the test of choice in most clinical settings to determine if an individual has infectious mononucleosis. (medscape.com)
- One must consider that the heterophile antibody test results may be negative early in the course of EBV infectious mononucleosis. (medscape.com)
- Patients who remain heterophile negative after 6 weeks with a mononucleosis illness should be considered as having heterophile-negative infectious mononucleosis. (medscape.com)
- These may be considered in patients with suspected infectious mononucleosis who have a negative heterophile test. (medscape.com)
Monospot1
- Agglutination of horse RBCs on exposure to heterophile antibodies is the basis of the Monospot test. (medscape.com)
Paul-Bunnell3
- Transient production of heterophile antibodies is seen in EBV infection and is known as Paul-Bunnell antibodies . (medscape.com)
- The Paul-Bunnell test for heterophile antibodies is based on the fact that serum obtained from patients with acute mononucleosis contains antibodies that agglutinate sheep, or more sensitivity, horse red blood cells (RBCs) but not guinea pig kidney cells in a tube dilution assay. (medscape.com)
- Sheep RBCs agglutinate in the presence of heterophile antibodies and are the basis for the Paul-Bunnell test. (medscape.com)
Serum6
- One hundred thirty-two positive heterophile antibody-tested serum samples were obtained from 2 tertiary care facilities in Boston to assess for HIV, and all tested negative for HIV plasma RNA. (nih.gov)
- The effect of heterophile antibodies in the QuantiFERON ® -TB Gold IT ELISA is minimized by the addition of normal mouse serum to the green diluent and the use of F(ab')2 monoclonal antibody fragments as the IFN-γ capture antibody coated the microplate wells. (cdc.gov)
- 3. Phantoms in the assay tube: heterophile antibody interferences in serum thyroglobulin assays. (nih.gov)
- 9. Markedly elevated serum thyroglobulin associated with heterophile antibodies: a cautionary tale. (nih.gov)
- 17. The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation. (nih.gov)
- In 1932, Paul and Bunnell discovered that serum from symptomatic patients had antibodies that agglutinate the red blood cells (RBCs) of unrelated species, the "heterophile antibodies. (medscape.com)
Agglutination1
- Twelve persons with positive tests had blood redrawn and tested at a reference laboratory in Puerto Rico using the same heterophile agglutination test. (cdc.gov)
Measurement2
- 2. Heterophile antibodies rarely influence the measurement of thyroglobulin and thyroglobulin antibodies in differentiated thyroid cancer patients. (nih.gov)
- 4. Heterophile antibodies may falsely increase or decrease thyroglobulin measurement in patients with differentiated thyroid carcinoma. (nih.gov)
Secretion1
- Elevated levels of IFN-γ in the Nil sample may occur with the presence of heterophile antibodies, or to intrinsic IFN-γ secretion. (cdc.gov)
Species2
- [ 50 ] These are antibodies that agglutinate cells from other species and are not directed against Epstein-Barr virus. (medscape.com)
- In a number of instances it is possible by repeatcé rapid pas- Si.ges through & susceptible host to enhance markvily the viruience of en- Cupsuleted pneumococci for this particular species. (nih.gov)
Test9
- A white blood cell (WBC) count and heterophile antibody test should be done, along with a rapid test for streptococcal pharyngitis. (medscape.com)
- A second heterophile antibody test can be ordered after 1-2 weeks in such cases. (medscape.com)
- however, the diagnosis should be confirmed with a heterophile antibody test or through EBV-specific antibodies. (medscape.com)
- Once a reactive heterophile antibody is present, it is not necessary to test for specific antibodies to EBV. (medscape.com)
- In patients with a compatible syndrome and negative heterophile antibodies, the test can be repeated if the patient is early in their clinical course. (medscape.com)
- The mononucleosis spot test looks for 2 antibodies in the blood. (medlineplus.gov)
- A negative test means there were no heterophile antibodies detected. (medlineplus.gov)
- A positive test means heterophile antibodies are present. (medlineplus.gov)
- On October 3, another heterophile test (Monosticon) was used. (cdc.gov)
Diagnostic1
- Reactive heterophile antibodies in a patient with the typical symptoms are diagnostic of EBV and further testing for specific antibodies to EBV is not necessary. (medscape.com)
Samples1
- The Nil samples adjust for background, heterophile antibody effects, or non-specific IFN-γ in blood samples. (cdc.gov)
Response2
- The graph below demonstrates the antibody response to Epstein-Barr virus. (medscape.com)
- Antibody response to Epstein-Barr virus. (medscape.com)
Production1
- To achieve effective hapten presentation on the carrier protein for antibody production, immunizing haptens with a rigid double-bonded hydrocarbon linker introduced at different positions on the target molecule were synthesized as well as coating haptens that mimic a characteristic fragment of the molecule. (nih.gov)
Weeks1
- The highest number of antibodies occurs 2 to 5 weeks after mono begins. (medlineplus.gov)